Jeena Sikho
Jeena Sikho Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
Targeting INR 3,000 crores turnover within the next 3 to 5 years, aiming to achieve it before 5 years. Target turnover of INR 3,000 crores within 3 to 5 years, aiming to achieve it preferably before 5 years.
From Jeena Sikho's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Targeting INR 3,000 crores turnover within the next 3 to 5 years, aiming to achieve it before 5 years.
- Committed to approximately 30% year-on-year growth in revenue.
- Both hospital business and product business expected to grow equally, complementing each other.
- Expanding bed capacity to 7,000 to 10,000 beds with a target occupancy of 75-80%.
- Focus on preventive healthcare to increase healthy patient base, reducing sick patient dependency.
- Quarterly volume growth observed: IPD volume up 33%, OPD volume 22%, and daycare volume 31% YoY.
- Increasing repeat customers and daycare patient counts, promoting recurring care.
- Growth driven by expanding product portfolio, e-commerce, and wellness centers.
- Government business reduced to minimize receivables; focus shifted to cash-rich private business.
- New wellness centers and discounts introduced to attract underprivileged segments, increasing patient volume.
Profitability & Margins
See what Jeena Sikho said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Jeena Sikho Lifecare Limited is actively working on hospital expansion, aiming to increase bed capacity (currently 2,400 operational beds with plans for more).
- They are investing in ultra-luxury wellness centers; the first center is launching with plans for three to four more similar projects.
- Capital is being allocated to technology upgrades, including new software implementation for patient retention and real-time data monitoring.
- Advertisement and marketing spend have increased to build brand awareness and promote both product and hospital business lines.
- Focus remains on creating an integrated healthcare ecosystem combining product sales and hospital services to drive long-term growth.
- The company targets INR3,000 crores turnover and INR1,000 crores PAT in the near future through these investments.
- Strategic partnerships and expansions in locations like Navi Mumbai, Andheri, Thane, Panvel, and other cities are underway.
- Emphasis on ethical and trust-based growth with better capital allocation and operational utilization.
Top-ranked in Leisure Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Jeena Sikho said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Jeena Sikho — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹222 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Jeena Sikho Lifecare Ltd's management said in earlier quarters
Others in Leisure Services this season
- Apeejay Surrendra Park Hotels Ltd (Q1 FY27)
Revenue for Q1 FY27 grew by 8% year-on-year to INR 167 crores; consolidated revenue was up 10% to INR 172 crores. Key concall takeaways from Apeejay Surrendra…
- Jungle Camps India Ltd (Q1 FY27)
Kukru property investment of about ₹7–7.5 crore planned to be operational by FY28. Key concall takeaways from Jungle Camps India Ltd's Q1 FY27 earnings call…
- Imagicaaworld Entertainment Ltd (Q1 FY27)
Revenue from operations grew 20% YoY to INR178 crores in Q1 FY27, driven by strong footfalls and peak season demand. Key concall takeaways from Imagicaaworld…
- Sapphire Foods India Ltd (Q1 FY27)
Overall, consolidated revenue grew 15% in Q1 FY ‘27, the best in 11 quarters, with 37% adjusted EBITDA growth. Key concall takeaways from Sapphire Foods India…
Frequently Asked Questions
What were Jeena Sikho Q1 FY27 results?
Targeting INR 3,000 crores turnover within the next 3 to 5 years, aiming to achieve it before 5 years. Target turnover of INR 3,000 crores within 3 to 5 years, aiming to achieve it preferably before 5 years.
What is Jeena Sikho share price analysis?
Jeena Sikho currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 26.6 with a market cap of ₹6,282 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jeena Sikho planning capital expenditure?
Jeena Sikho Lifecare Limited is actively working on hospital expansion, aiming to increase bed capacity (currently 2,400 operational beds with plans for more).
Keep Jeena Sikho on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.